Search

Your search keyword '"Chen, Titi"' showing total 9 results
Start Over Author "Chen, Titi" Publication Year Range Last 3 years
9 results on '"Chen, Titi"'

4. WCN24-758 RECOGNITION OF LOCAL INVESTIGATORS IN AUTHORSHIP OF COLLABORATIVE KIDNEY RESEARCH CONDUCTED IN LOW- AND LOWERMIDDLE INCOME COUNTRIES

Author

Wijewickrama, Eranga, primary, Chanchlani, Rahul, additional, Wong, Michelle, additional, Kumar, Vivek, additional, Karam, Sabine, additional, Chen, Titi, additional, Erikpo, Udeme, additional, Tannor, Elliot, additional, Calice-Silva, Viviane, additional, Anandh, Urmila, additional, Bajpai, Divya, additional, Abdul Hafidz, Muhamed Iqbal, additional, Tian, Amanda, additional, Opare-Addo, Priscilla, additional, Edeki, Imuetinyan, additional, and Kalyesubula, Robert, additional

Published
2024
Full Text
View/download PDF

6. Nurturing Global Leadership, Advocacy, Research, and Collegiality: The Unique Experience of The International Society of Nephrology Emerging Leaders Program

Author

Karam, Sabine, primary, Abdul Hafidz, Muhammad Iqbal, additional, Calice-Silva, Viviane, additional, Chen, Titi, additional, Dupuis, Sophie, additional, Ekrikpo, Udeme E., additional, Francis, Anna, additional, Jha, Vivekanand, additional, Kalyesubula, Robert, additional, Kumar, Vivek, additional, Nakhoul, Georges, additional, Pereira-Kamath, Nikhil, additional, Tannor, Elliot K., additional, Tran, Anh, additional, Wijewickrama, Eranga, additional, Wong, Michelle M.Y., additional, and Chanchlani, Rahul, additional

Published
2023
Full Text
View/download PDF

7. Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

Author

Francis, Anna, Wainstein, Marina, Irish, Georgina, Abdul Hafidz, Muhammad Iqbal, Chen, Titi, Cho, Yeoungjee, Htay, Htay, Kanjanabuch, Talerngsak, Lalji, Rowena, Neuen, Brendon L., See, Emily, Shah, Anim, Smyth, Brendan, Tungsanga, Somkanya, Viecelli, Andrea, Yeung, Emily K., Arruebo, Silvia, Bello, Aminu K., Caskey, Fergus J., Damster, Sandrine, Donner, Jo-Ann, Jha, Vivekanand, Johnson, David W., Levin, Adeera, Malik, Charu, Nangaku, Masaomi, Okpechi, Ikechi G., Tonelli, Marcello, Ye, Feng, Wong, Muh Geot, Bavanandan, Sunita, Abdul Gafor, Abdul Halim, Amouzegar, Atefeh, Bennett, Paul, Chicano, Sonia L., Davids, M. Razeen, Davison, Sara N., Diongole, Hassane M., Divyaveer, Smita, Ekrikpo, Udeme E., Ethier, Isabelle, Fong, Voon Ken, Fung, Winston Wing-Shing, Ghimire, Anukul, Gopal, Basu, Phan, Hai An Ha, Harris, David C.H., Houston, Ghenette, Ibrahim, Kwaifa Salihu, Jardine, Meg J., Jindal, Kailash, Kantachuvesiri, Surasak, Kelly, Dearbhla M., Kerr, Peter, Kim, Siah, Krishnasamy, Rathika, Kwek, Jia Liang, Lee, Vincent, Liew, Adrian, Lim, Chiao Yuen, Lydia, Aida, Nalado, Aisha M., Olanrewaju, Timothy O., Osman, Mohamed A., Petrova, Anna, Pyar, Khin Phyu, Riaz, Parnian, Saad, Syed, Sakajiki, Aminu Muhammad, Sengthavisouk, Noot, Sozio, Stephen M., Srisawat, Nattachai, Tan, Eddie, Tiv, Sophanny, Tomacruz Amante, Isabelle Dominique, Villanueva, Anthony Russell, Walker, Rachael, Walker, Robert, and Zaidi, Deenaz

Abstract

The International Society of Nephrology (ISN) region of Oceania and South East Asia (OSEA) is a mix of high- and low-income countries, with diversity in population demographics and densities. Three iterations of the ISN-Global Kidney Health Atlas (GKHA) have been conducted, aiming to deliver in-depth assessments of global kidney care across the spectrum from early detection of CKD to treatment of kidney failure. This paper reports the findings of the latest ISN-GKHA in relation to kidney-care capacity in the OSEA region. Among the 30 countries and territories in OSEA, 19 (63%) participated in the ISN-GKHA, representing over 97% of the region’s population. The overall prevalence of treated kidney failure in the OSEA region was 1203 per million population (pmp), 45% higher than the global median of 823 pmp. In contrast, kidney replacement therapy (KRT) in the OSEA region was less available than the global median (chronic hemodialysis, 89% OSEA region vs. 98% globally; peritoneal dialysis, 72% vs. 79%; kidney transplantation, 61% vs. 70%). Only 56% of countries could provide access to dialysis to at least half of people with incident kidney failure, lower than the global median of 74% of countries with available dialysis services. Inequalities in access to KRT were present across the OSEA region, with widespread availability and low out-of-pocket costs in high-income countries and limited availability, often coupled with large out-of-pocket costs, in middle- and low-income countries. Workforce limitations were observed across the OSEA region, especially in lower-middle–income countries. Extensive collaborative work within the OSEA region and globally will help close the noted gaps in kidney-care provision.

Published
2024
Full Text
View/download PDF

8. Access to and barriers to access for essential medicines in nephrology and related non-communicable diseases: a scoping review protocol

Author

Wong, Michelle, Calice-Silva, Viviane, Tannor, Elliot, Nakhoul, Georges, Kumar, Vivek, Hafidz, Muhammad, Chanchlani, Rahul, Chen, Titi, Ekrikpo, Udeme, Francis, Anna, Kalyesubula, Robert, Karam, Sabine, Pereira-Kamath, Nikhil, Wijewickrama, Eranga, Sanger, Stephanie, Vanhonsebrouck, Pauline, and Jha, Vivekanand

Subjects
access, Medicine and Health Sciences, nephrology, essential medicines
Abstract

Access to essential medicines for treatment of non-communicable diseases (NCDs) is lacking in low- and low-middle income countries. In nephrology, access to essential medicines is especially important to reduce risk of chronic kidney disease (CKD) progression, as kidney replacement therapy is unavailable or cost-prohibitive in many regions of the world. As part of the International Society of Nephrology (ISN) Emerging Leaders Program’s mandate to improve health promotion and access to prevention and management of kidney diseases globally, this scoping review aims to understand the extent of evidence regarding: 1) access to essential medicines for CKD and related NCDs, 2) barriers to access, and 3) interventions to improve access.

Published
2022
Full Text
View/download PDF

9. Access to and Barriers to Access for Essential Medicines in Nephrology and Related Non-Communicable Diseases: A Scoping Review Protocol

Author

Wong, Michelle Mon Yee, primary, Calice-Silva, Viviane, additional, Tannor, Elliot K., additional, Nakoul, Georges, additional, Kumar, Vivek, additional, Hafidz, Muhammad Iqbal Abdul, additional, Chanchlani, Rahul, additional, Chen, Titi, additional, Ekrikpo, Udeme E., additional, Francis, Anna, additional, Kalyesubula, Robert, additional, Karam, Sabine, additional, Pereira-Kamath, Nikhil, additional, Wijewickrama, Eranga, additional, Sanger, Stephanie, additional, and Jha, Vivekanand, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results